BioNexus Gene Lab Stockholders Back Governance and Incentive Plan
I'm PortAI, I can summarize articles.
BioNexus Gene Lab Corp (BGLC) held its 2025 Annual Meeting of Stockholders on December 24, 2025, where shareholders elected four directors and approved the 2025 Equity Incentive Plan. The appointment of JP Centurion & Partners PLT as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was also ratified. The meeting indicated strong shareholder support for the company's governance and compensation framework.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments